Corticotropin-releasing hormone antagonist (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Corticotropin-releasing hormone antagonist" in English language version.

refsWebsite

Global rank English rank

12nih.gov

4^th place

7doi.org

2^nd place

2harvard.edu

18^th place

17^th place

1semanticscholar.org

11^th place

8^th place

1jstor.org

26^th place

20^th place

doi.org

Zoumakis E, Rice KC, Gold PW, Chrousos GP (November 2006). "Potential uses of corticotropin-releasing hormone antagonists". Annals of the New York Academy of Sciences. 1083 (1): 239–51. Bibcode:2006NYASA1083..239Z. doi:10.1196/annals.1367.021. PMID 17148743. S2CID 7731338.
Taché Y (July 2004). "Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?". Gut. 53 (7): 919–21. doi:10.1136/gut.2003.036400. PMC 1774121. PMID 15194633.
Reul JM, Holsboer F (March 2002). "On the role of corticotropin-releasing hormone receptors in anxiety and depression". Dialogues in Clinical Neuroscience. 4 (1): 31–46. doi:10.31887/DCNS.2002.4.1/jreul. PMC 3181666. PMID 22033745.
Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang SP, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, Stock EG (May 2010). "Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder". Depression and Anxiety. 27 (5): 417–25. doi:10.1002/da.20695. PMID 20455246.
Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW (May 2000). "Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates". Proceedings of the National Academy of Sciences of the United States of America. 97 (11): 6079–84. Bibcode:2000PNAS...97.6079H. doi:10.1073/pnas.97.11.6079. JSTOR 122584. PMC 18561. PMID 10823952.
Künzel HE, Zobel AW, Nickel T, Ackl N, Uhr M, Sonntag A, Ising M, Holsboer F (2003). "Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects". Journal of Psychiatric Research. 37 (6): 525–33. doi:10.1016/S0022-3956(03)00070-0. PMID 14563384.
Vulliémoz NR, Xiao E, Xia-Zhang L, Rivier J, Ferin M (March 2008). "Astressin B, a nonselective corticotropin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing hormone pulse frequency in the ovariectomized rhesus monkey". Endocrinology. 149 (3): 869–74. doi:10.1210/en.2007-1350. PMC 2275354. PMID 18063681.

harvard.edu

ui.adsabs.harvard.edu

Zoumakis E, Rice KC, Gold PW, Chrousos GP (November 2006). "Potential uses of corticotropin-releasing hormone antagonists". Annals of the New York Academy of Sciences. 1083 (1): 239–51. Bibcode:2006NYASA1083..239Z. doi:10.1196/annals.1367.021. PMID 17148743. S2CID 7731338.
Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW (May 2000). "Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates". Proceedings of the National Academy of Sciences of the United States of America. 97 (11): 6079–84. Bibcode:2000PNAS...97.6079H. doi:10.1073/pnas.97.11.6079. JSTOR 122584. PMC 18561. PMID 10823952.

jstor.org

Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW (May 2000). "Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates". Proceedings of the National Academy of Sciences of the United States of America. 97 (11): 6079–84. Bibcode:2000PNAS...97.6079H. doi:10.1073/pnas.97.11.6079. JSTOR 122584. PMC 18561. PMID 10823952.

nih.gov

pubmed.ncbi.nlm.nih.gov

Zoumakis E, Rice KC, Gold PW, Chrousos GP (November 2006). "Potential uses of corticotropin-releasing hormone antagonists". Annals of the New York Academy of Sciences. 1083 (1): 239–51. Bibcode:2006NYASA1083..239Z. doi:10.1196/annals.1367.021. PMID 17148743. S2CID 7731338.
McCarthy JR, Heinrichs SC, Grigoriadis DE (May 1999). "Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications". Current Pharmaceutical Design. 5 (5): 289–315. PMID 10213797.
Taché Y (July 2004). "Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?". Gut. 53 (7): 919–21. doi:10.1136/gut.2003.036400. PMC 1774121. PMID 15194633.
Reul JM, Holsboer F (March 2002). "On the role of corticotropin-releasing hormone receptors in anxiety and depression". Dialogues in Clinical Neuroscience. 4 (1): 31–46. doi:10.31887/DCNS.2002.4.1/jreul. PMC 3181666. PMID 22033745.
Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang SP, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, Stock EG (May 2010). "Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder". Depression and Anxiety. 27 (5): 417–25. doi:10.1002/da.20695. PMID 20455246.
Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW (May 2000). "Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates". Proceedings of the National Academy of Sciences of the United States of America. 97 (11): 6079–84. Bibcode:2000PNAS...97.6079H. doi:10.1073/pnas.97.11.6079. JSTOR 122584. PMC 18561. PMID 10823952.
Künzel HE, Zobel AW, Nickel T, Ackl N, Uhr M, Sonntag A, Ising M, Holsboer F (2003). "Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects". Journal of Psychiatric Research. 37 (6): 525–33. doi:10.1016/S0022-3956(03)00070-0. PMID 14563384.
Vulliémoz NR, Xiao E, Xia-Zhang L, Rivier J, Ferin M (March 2008). "Astressin B, a nonselective corticotropin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing hormone pulse frequency in the ovariectomized rhesus monkey". Endocrinology. 149 (3): 869–74. doi:10.1210/en.2007-1350. PMC 2275354. PMID 18063681.

ncbi.nlm.nih.gov

Taché Y (July 2004). "Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?". Gut. 53 (7): 919–21. doi:10.1136/gut.2003.036400. PMC 1774121. PMID 15194633.
Reul JM, Holsboer F (March 2002). "On the role of corticotropin-releasing hormone receptors in anxiety and depression". Dialogues in Clinical Neuroscience. 4 (1): 31–46. doi:10.31887/DCNS.2002.4.1/jreul. PMC 3181666. PMID 22033745.
Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW (May 2000). "Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates". Proceedings of the National Academy of Sciences of the United States of America. 97 (11): 6079–84. Bibcode:2000PNAS...97.6079H. doi:10.1073/pnas.97.11.6079. JSTOR 122584. PMC 18561. PMID 10823952.
Vulliémoz NR, Xiao E, Xia-Zhang L, Rivier J, Ferin M (March 2008). "Astressin B, a nonselective corticotropin-releasing hormone receptor antagonist, prevents the inhibitory effect of ghrelin on luteinizing hormone pulse frequency in the ovariectomized rhesus monkey". Endocrinology. 149 (3): 869–74. doi:10.1210/en.2007-1350. PMC 2275354. PMID 18063681.

semanticscholar.org

api.semanticscholar.org

Zoumakis E, Rice KC, Gold PW, Chrousos GP (November 2006). "Potential uses of corticotropin-releasing hormone antagonists". Annals of the New York Academy of Sciences. 1083 (1): 239–51. Bibcode:2006NYASA1083..239Z. doi:10.1196/annals.1367.021. PMID 17148743. S2CID 7731338.